Bayer’s gene therapy CDMO Viralgen cuts ribbon on first phase of $142M viral vector expansion

Bayer’s gene therapy CDMO Viralgen cuts ribbon on first phase of $142M viral vector expansion
fkansteiner
Wed, 06/30/2021 – 10:28